{"id":3563,"date":"2022-06-28T15:11:06","date_gmt":"2022-06-28T12:11:06","guid":{"rendered":"https:\/\/info.e-med.co.il\/remsima\/?p=3563"},"modified":"2023-10-25T15:14:29","modified_gmt":"2023-10-25T12:14:29","slug":"comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis","status":"publish","type":"post","link":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/","title":{"rendered":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis"},"content":{"rendered":"<h3 class=\"title\" dir=\"ltr\" style=\"text-align: left;\">Abstract<\/h3>\n<div id=\"eng-abstract\" class=\"abstract-content selected\">\n<p dir=\"ltr\" style=\"text-align: left;\"><strong class=\"sub-title\">Background and aims:\u00a0<\/strong>There are limited comparative data for infliximab and vedolizumab in inflammatory bowel disease patients.<\/p>\n<p style=\"text-align: right;\"><strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35676620\/\" target=\"_blank\" rel=\"noopener\">\u05dc\u05d4\u05de\u05e9\u05da \u05e7\u05e8\u05d9\u05d0\u05d4<\/a><\/strong><\/p>\n<\/div>\n<p dir=\"ltr\">Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, Louis E, Luk\u00e1\u0161 M, Reinisch W, Roblin X, Jang M, Byun HG, Kim DH, Lee SJ, Atreya R. Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol. 2022 Jun 8;22(1):291. doi: 10.1186\/s12876-022-02347-1. PMID: 35676620; PMCID: PMC9178865.<\/p>\n","protected":false},"excerpt":{"rendered":"<p dir=\"ltr\"><strong>Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291 <\/strong><\/p>\n","protected":false},"author":2,"featured_media":3564,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[28,26,24],"tags":[],"class_list":["post-3563","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article-en","category-research","category-updates-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"&#039;\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3&#039;\"\/>\n\t<meta name=\"keywords\" content=\"article,\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd,\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"he_IL\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Remsima | \u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de&quot;\u05d2\/\u05de&quot;\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima\" \/>\n\t\t<meta property=\"og:description\" content=\"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-06-28T12:11:06+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-10-25T12:14:29+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#article\",\"name\":\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima\",\"headline\":\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis\",\"author\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/10\\\/118942730-ibd.jpg\",\"width\":414,\"height\":414,\"caption\":\"Human Digestive System Illustration\"},\"datePublished\":\"2022-06-28T15:11:06+03:00\",\"dateModified\":\"2023-10-25T15:14:29+03:00\",\"inLanguage\":\"he-IL\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#webpage\"},\"articleSection\":\"Article, \\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd, \\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"position\":2,\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"position\":3,\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\",\"item\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#listItem\",\"name\":\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/updates-news\\\/#listItem\",\"name\":\"\\u05e2\\u05d3\\u05db\\u05d5\\u05e0\\u05d9\\u05dd\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#listItem\",\"position\":4,\"name\":\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/research\\\/#listItem\",\"name\":\"\\u05de\\u05d7\\u05e7\\u05e8\\u05d9\\u05dd \\u05d5\\u05e4\\u05e8\\u05e1\\u05d5\\u05de\\u05d9\\u05dd\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\",\"name\":\"\\u05e4\\u05d0\\u05d3\\u05d0\\u05d2\\u05d9\\u05e1 \\u05d9\\u05e9\\u05e8\\u05d0\\u05dc \\u05e1\\u05d5\\u05db\\u05e0\\u05d5\\u05d9\\u05d5\\u05ea \\u05d1\\u05e2\\\"\\u05de\",\"description\":\"\\u05e8\\u05de\\u05e1\\u05d9\\u05de\\u05d4 120 \\u05de\\\"\\u05d2\\\/\\u05de\\\"\\u05dc \\u05ea\\u05ea -\\u05e2\\u05d5\\u05e8\\u05d9 \\u05d4\\u05d9\\u05e0\\u05d5 \\u05d4\\u05d0\\u05d9\\u05e0\\u05e4\\u05dc\\u05d9\\u05e7\\u05e1\\u05d9\\u05de\\u05d0\\u05d1 \\u05d4\\u05d9\\u05d7\\u05d9\\u05d3 \\u05db\\u05d9\\u05d5\\u05dd \\u05d4\\u05e0\\u05d9\\u05ea\\u05df \\u05d1\\u05de\\u05ea\\u05df \\u05ea\\u05ea-\\u05e2\\u05d5\\u05e8\\u05d9\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/11\\\/remsima_150.jpg\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#organizationLogo\",\"width\":150,\"height\":150},\"image\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/\",\"name\":\"'\\u05de\\u05e2\\u05e8\\u05db\\u05ea \\u05d0\\u05d9\\u05de\\u05d3'\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a33eb712ef50ecea3e80558c3ebca581471b3c91aeab90167c90d04c73f5e3b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"'\\u05de\\u05e2\\u05e8\\u05db\\u05ea \\u05d0\\u05d9\\u05de\\u05d3'\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#webpage\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/\",\"name\":\"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima\",\"description\":\"Peyrin\\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291\",\"inLanguage\":\"he-IL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/author\\\/naama2shomroni23\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/files\\\/2023\\\/10\\\/118942730-ibd.jpg\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#mainImage\",\"width\":414,\"height\":414,\"caption\":\"Human Digestive System Illustration\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\\\/#mainImage\"},\"datePublished\":\"2022-06-28T15:11:06+03:00\",\"dateModified\":\"2023-10-25T15:14:29+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#website\",\"url\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/\",\"name\":\"Remsima\",\"description\":\"\\u05e8\\u05de\\u05e1\\u05d9\\u05de\\u05d4 120 \\u05de\\\"\\u05d2\\\/\\u05de\\\"\\u05dc \\u05ea\\u05ea -\\u05e2\\u05d5\\u05e8\\u05d9 \\u05d4\\u05d9\\u05e0\\u05d5 \\u05d4\\u05d0\\u05d9\\u05e0\\u05e4\\u05dc\\u05d9\\u05e7\\u05e1\\u05d9\\u05de\\u05d0\\u05d1 \\u05d4\\u05d9\\u05d7\\u05d9\\u05d3 \\u05db\\u05d9\\u05d5\\u05dd \\u05d4\\u05e0\\u05d9\\u05ea\\u05df \\u05d1\\u05de\\u05ea\\u05df \\u05ea\\u05ea-\\u05e2\\u05d5\\u05e8\\u05d9\",\"inLanguage\":\"he-IL\",\"publisher\":{\"@id\":\"https:\\\/\\\/info.e-med.co.il\\\/remsima\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima","description":"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291","canonical_url":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/","robots":"max-image-preview:large","keywords":"article,\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd,\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#article","name":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima","headline":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis","author":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"publisher":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/10\/118942730-ibd.jpg","width":414,"height":414,"caption":"Human Digestive System Illustration"},"datePublished":"2022-06-28T15:11:06+03:00","dateModified":"2023-10-25T15:14:29+03:00","inLanguage":"he-IL","mainEntityOfPage":{"@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#webpage"},"isPartOf":{"@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#webpage"},"articleSection":"Article, \u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd, \u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"},{"@type":"BreadcrumbList","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima#listItem","position":1,"name":"Home","item":"https:\/\/info.e-med.co.il\/remsima","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","position":2,"name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","item":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd"},"previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","position":3,"name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd","item":"https:\/\/info.e-med.co.il\/remsima\/research\/","nextItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#listItem","name":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis"},"previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/#listItem","name":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd"}},{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#listItem","position":4,"name":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis","previousItem":{"@type":"ListItem","@id":"https:\/\/info.e-med.co.il\/remsima\/research\/#listItem","name":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd"}}]},{"@type":"Organization","@id":"https:\/\/info.e-med.co.il\/remsima\/#organization","name":"\u05e4\u05d0\u05d3\u05d0\u05d2\u05d9\u05e1 \u05d9\u05e9\u05e8\u05d0\u05dc \u05e1\u05d5\u05db\u05e0\u05d5\u05d9\u05d5\u05ea \u05d1\u05e2\"\u05de","description":"\u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de\"\u05d2\/\u05de\"\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","url":"https:\/\/info.e-med.co.il\/remsima\/","logo":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/11\/remsima_150.jpg","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#organizationLogo","width":150,"height":150},"image":{"@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author","url":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/","name":"'\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3'","image":{"@type":"ImageObject","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a33eb712ef50ecea3e80558c3ebca581471b3c91aeab90167c90d04c73f5e3b?s=96&d=mm&r=g","width":96,"height":96,"caption":"'\u05de\u05e2\u05e8\u05db\u05ea \u05d0\u05d9\u05de\u05d3'"}},{"@type":"WebPage","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#webpage","url":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/","name":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima","description":"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291","inLanguage":"he-IL","isPartOf":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#website"},"breadcrumb":{"@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#breadcrumblist"},"author":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"creator":{"@id":"https:\/\/info.e-med.co.il\/remsima\/author\/naama2shomroni23\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/info.e-med.co.il\/remsima\/files\/2023\/10\/118942730-ibd.jpg","@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#mainImage","width":414,"height":414,"caption":"Human Digestive System Illustration"},"primaryImageOfPage":{"@id":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/#mainImage"},"datePublished":"2022-06-28T15:11:06+03:00","dateModified":"2023-10-25T15:14:29+03:00"},{"@type":"WebSite","@id":"https:\/\/info.e-med.co.il\/remsima\/#website","url":"https:\/\/info.e-med.co.il\/remsima\/","name":"Remsima","description":"\u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de\"\u05d2\/\u05de\"\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","inLanguage":"he-IL","publisher":{"@id":"https:\/\/info.e-med.co.il\/remsima\/#organization"}}]},"og:locale":"he_IL","og:site_name":"Remsima | \u05e8\u05de\u05e1\u05d9\u05de\u05d4 120 \u05de&quot;\u05d2\/\u05de&quot;\u05dc \u05ea\u05ea -\u05e2\u05d5\u05e8\u05d9 \u05d4\u05d9\u05e0\u05d5 \u05d4\u05d0\u05d9\u05e0\u05e4\u05dc\u05d9\u05e7\u05e1\u05d9\u05de\u05d0\u05d1 \u05d4\u05d9\u05d7\u05d9\u05d3 \u05db\u05d9\u05d5\u05dd \u05d4\u05e0\u05d9\u05ea\u05df \u05d1\u05de\u05ea\u05df \u05ea\u05ea-\u05e2\u05d5\u05e8\u05d9","og:type":"article","og:title":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima","og:description":"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291","og:url":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/","article:published_time":"2022-06-28T12:11:06+00:00","article:modified_time":"2023-10-25T12:14:29+00:00","twitter:card":"summary","twitter:title":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | Remsima","twitter:description":"Peyrin\u2011Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291"},"aioseo_meta_data":{"post_id":"3563","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_custom_image_width":null,"og_custom_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"none","tabs":null,"priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"created":"2023-10-25 12:11:03","updated":"2026-05-15 00:39:37","primary_term":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"twitter_image_url":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"limit_modified_date":false,"ai":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\/updates-news\/\" title=\"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd\">\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/info.e-med.co.il\/remsima\/research\/\" title=\"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd\">\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tComparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/info.e-med.co.il\/remsima"},{"label":"\u05e2\u05d3\u05db\u05d5\u05e0\u05d9\u05dd","link":"https:\/\/info.e-med.co.il\/remsima\/updates-news\/"},{"label":"\u05de\u05d7\u05e7\u05e8\u05d9\u05dd \u05d5\u05e4\u05e8\u05e1\u05d5\u05de\u05d9\u05dd","link":"https:\/\/info.e-med.co.il\/remsima\/research\/"},{"label":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis","link":"https:\/\/info.e-med.co.il\/remsima\/comparative-efficacy-and-safety-of-infliximab-and-vedolizumab-therapy-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis\/"}],"_links":{"self":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/comments?post=3563"}],"version-history":[{"count":1,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3563\/revisions"}],"predecessor-version":[{"id":3565,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/posts\/3563\/revisions\/3565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/media\/3564"}],"wp:attachment":[{"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/media?parent=3563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/categories?post=3563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.e-med.co.il\/remsima\/wp-json\/wp\/v2\/tags?post=3563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}